Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yikon Genomics, often referred to as Yickon, is a leading biotechnology company specializing in single-cell sequencing and precision genetic testing. Founded by world-renowned scientist Dr. Sunney Xie, the company is built upon the proprietary Multiple Annealing and Looping Based Amplification Cycles (MALBAC) technology, which provides superior uniformity in whole genome amplification. Yikon primarily focuses on reproductive health, offering a comprehensive suite of Preimplantation Genetic Testing (PGT) solutions to improve IVF success rates and prevent the transmission of genetic disorders. Their product portfolio includes kits for aneuploidy screening, monogenic disease detection, and non-invasive chromosome screening. Beyond reproductive medicine, the company is actively applying its single-cell platform to oncology diagnostics and liquid biopsy applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yickon.